Quantitative Mass Spectrometry Imaging Reveals Mutation Status-independent Lack of Imatinib in Liver Metastases of Gastrointestinal Stromal Tumors

Mass spectrometry imaging (MSI) is an enabling technology for label-free drug disposition studies at high spatial resolution in life science- and pharmaceutical research. We present the first extensive clinical matrix-assisted laser desorption/ionization (MALDI) quantitative mass spectrometry imagin...

Descripción completa

Detalles Bibliográficos
Autores principales: Abu Sammour, Denis, Marsching, Christian, Geisel, Alexander, Erich, Katrin, Schulz, Sandra, Ramallo Guevara, Carina, Rabe, Jan-Hinrich, Marx, Alexander, Findeisen, Peter, Hohenberger, Peter, Hopf, Carsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6650609/
https://www.ncbi.nlm.nih.gov/pubmed/31337874
http://dx.doi.org/10.1038/s41598-019-47089-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6650609/
https://www.ncbi.nlm.nih.gov/pubmed/31337874
http://dx.doi.org/10.1038/s41598-019-47089-5

Ejemplares similares